Namenda and Breastfeeding
Since no studies have been conducted on Namenda and breastfeeding, it is not known whether the drug passes through breast milk. It is important to note, however, that Namenda is only approved for treating Alzheimer's disease, a condition that is not likely to occur in women of childbearing age. You should talk to your healthcare provider about Namenda and breastfeeding in your particular situation.
At this time, it is unknown if Namenda® (memantine hydrochloride) passes through breast milk. If you are breastfeeding or are thinking about breastfeeding, you should talk with your healthcare provider before taking Namenda. Keep in mind that this drug is approved only for treating Alzheimer's disease, a condition that is unlikely to occur in women of childbearing age.
No studies have been conducted on whether Namenda passes through breast milk in women. Also, because the drug has not been adequately studied in any infants or children, it is not known if it could have any negative effects on an infant if it does pass through breast milk.
Talking With Your Healthcare Provider About Namenda and BreastfeedingYou should talk with your healthcare provider about Namenda and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision about Namenda and breastfeeding that is right for you.